Ok I took the time to listen to the presentation last night. The financials are what should have been expected, no surprise. As has been discussed the remainder was very helpful and indeed it should be described as exciting. The main concern that I have and I also think the market is that the BLA is taking far to long to submit. I anticipated possible marketing before the end of the year . This will cost around 40- 50 million in lost sales worse is that anticipated income would have balanced the books. Come on SI , explain to the market the delay , is it because of FDA due process. Or is it because MSB hasn't got the resources to cope with the paperwork . Is it necessary to wait for FDA feed back on each module before preparing the next module. The market needs to be informed , then and only then will the market become excited by these great announcements.
MSB Price at posting:
$1.39 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)